文献速递疼痛医学

哌甲酯与吗啡联合治疗在大鼠慢性疼痛模型中的作用

Methylphenidate and Morphine Combination Therapy in a Rat Model of Chronic Pain.
PubMed 文献 · Anesth Analg · 2020-01-01

该研究在大鼠慢性疼痛模型中观察低剂量哌甲酯(MPH)与低剂量吗啡(MOR)联用的效果。结果显示联合用药可协同增强并延长MOR的镇痛作用,且低剂量MPH不增加运动活性或显著增强MOR的奖赏行为,提示可能产生吗啡节约效应。

要点

  • 慢性疼痛大鼠中,损伤后28天时2.5 mg/kg MOR镇痛效果弱于10 mg/kg MOR。
  • MPH 0.25 mg/kg与MOR 2.5 mg/kg联用在注射后30-90分钟协同增强并延长镇痛。
  • 低剂量MPH不增加运动活性,也未显著增强MOR奖赏行为。

核心结论

  • 低剂量MPH与MOR联用可能在慢性疼痛管理中产生吗啡节约效应。

研究设计与样本

  • 大鼠胫跗关节注射完全弗氏佐剂(CFA)诱导慢性疼痛模型。
  • 评估低剂量MPH(0.25 mg/kg)、低剂量MOR(2.5 mg/kg)及其联用的镇痛效果。
  • 采用von Frey测试评估伤害性行为,条件位置偏好(CPP)和旷场测试评估奖赏行为与运动活性。

主要发现

  • CFA大鼠损伤后28天,2.5 mg/kg MOR镇痛效果弱于10 mg/kg MOR,von Frey阈值均数差95%CI为-11.9 [-6.5至-17.3]克。

临床怎么用

  • 慢性疼痛管理或可考虑低剂量MPH与MOR联用以增强镇痛并减少MOR用量,但需临床研究验证。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incremental dose of opioids used in chronic pain management often leads to a reduced opioid analgesic effect, opioid misuse, and addiction. Central dopamine (DA) dysfunction contributes to the chronicity of pain and a decreased opioid analgesic effect. Methylphenidate (MPH/Ritalin) enhances central DA function by inhibiting DA reuptake. In this study, we used a rat model of chronic pain to examine whether combination of MPH with morphine (MOR) would improve the MOR analgesic effect under a chronic pain condition. METHODS: Tibiotarsal joint Complete Freund's Adjuvant (CFA) injection in rats was utilized to induce chronic nociception. The analgesic effect of low-dose MPH (0.25 mg/kg), low-dose MOR (2.5 mg/kg), and their combination was examined in CFA rats. Nociceptive behavior was assessed by von Frey test. Conditioned place preference (CPP) and open field tests (OFTs) were used to examine the rewarding behavior and locomotor activity in rats, respectively. RESULTS: Our findings are as follows: (1) in CFA rats with chronic pain, 2.5 mg/kg of MOR had less analgesic effect than 10 mg/kg of MOR at 28 days after injury (95% confidence intervals [CIs] for difference of means of von Frey threshold in gram: -11.9 [-6.5 to -17.3]); (2) in the 1-hour time window of 30-90 minutes after injection, the combination of MPH (0.25 mg/kg) with MOR (2.5 mg/kg) increased synergistically and prolonged the analgesic effect in CFA rats as compared with MPH or MOR alone (P = .01 for MPH by MOR interaction, and 95% CIs for difference of means of von Frey threshold in gram: 3.3 [1.37-6.12] for the combination versus MPH and 3.2 [1.35-5.74] for the combination versus MOR); (3) at the low dose (0.25 mg/kg), MPH did not increase locomotor activity (MOR + MPH versus MOR, P = .13) nor significantly enhanced MOR reward behavior (MOR + MPH versus MOR, P = .63) in CFA rats. CONCLUSIONS: Our data suggest that a combination therapy using low-dose MPH and MOR may produce a MOR-sparing effect in chronic pain management.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. You Z, Ding W, Doheny JT, et al. Methylphenidate and Morphine Combination Therapy in a Rat Model of Chronic Pain. Anesth Analg. 2020. PMID: 31206430. doi:10.1213/ANE.0000000000004273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。